Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition

The present study investigated the effect of silibinin, the principal potential anti-inflammatory flavonoid contained in silymarin, a mixture of flavonolignans extracted from Silybum marianum seeds, on palmitate-induced insulin resistance in C2C12 myotubes and its potential molecular mechanisms. Sil...

Full description

Bibliographic Details
Main Authors: H.B. Li, Y.R.Y. Yang, Z.J. Mo, Y. Ding, W.J. Jiang
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2015-05-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500440&lng=en&tlng=en
id doaj-b1dad858226b4854a1e7e08c8fd8f9bb
record_format Article
spelling doaj-b1dad858226b4854a1e7e08c8fd8f9bb2020-11-24T23:04:57ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2015-05-0148544044610.1590/1414-431X20144238S0100-879X2015000500440Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibitionH.B. LiY.R.Y. YangZ.J. MoY. DingW.J. JiangThe present study investigated the effect of silibinin, the principal potential anti-inflammatory flavonoid contained in silymarin, a mixture of flavonolignans extracted from Silybum marianum seeds, on palmitate-induced insulin resistance in C2C12 myotubes and its potential molecular mechanisms. Silibinin prevented the decrease of insulin-stimulated 2-NBDG (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose) uptake and the downregulation of glutamate transporter type 4 (GLUT4) translocation in C2C12 myotubes induced by palmitate. Meanwhile, silibinin suppressed the palmitate-induced decrease of insulin-stimulated Akt Ser473 phosphorylation, which was reversed by wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase (PI3K). We also found that palmitate downregulated insulin-stimulated Tyr632 phosphorylation of insulin receptor substrate 1 (IRS-1) and up-regulated IRS-1 Ser307 phosphorylation. These effects were rebalanced by silibinin. Considering several serine/threonine kinases reported to phosphorylate IRS-1 at Ser307, treatment with silibinin downregulated the phosphorylation of both c-Jun N-terminal kinase (JNK) and nuclear factor-κB kinase β (IKKβ), which was increased by palmitate in C2C12 myotubes mediating inflammatory status, whereas the phosphorylation of PKC-θ was not significantly modulated by silibinin. Collectively, the results indicated that silibinin prevented inhibition of the IRS-1/PI3K/Akt pathway, thus ameliorating palmitate-induced insulin resistance in C2C12 myotubes.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500440&lng=en&tlng=enSilibininInsulin resistancePalmitateC2C12
collection DOAJ
language English
format Article
sources DOAJ
author H.B. Li
Y.R.Y. Yang
Z.J. Mo
Y. Ding
W.J. Jiang
spellingShingle H.B. Li
Y.R.Y. Yang
Z.J. Mo
Y. Ding
W.J. Jiang
Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
Brazilian Journal of Medical and Biological Research
Silibinin
Insulin resistance
Palmitate
C2C12
author_facet H.B. Li
Y.R.Y. Yang
Z.J. Mo
Y. Ding
W.J. Jiang
author_sort H.B. Li
title Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
title_short Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
title_full Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
title_fullStr Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
title_full_unstemmed Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition
title_sort silibinin improves palmitate-induced insulin resistance in c2c12 myotubes by attenuating irs-1/pi3k/akt pathway inhibition
publisher Associação Brasileira de Divulgação Científica
series Brazilian Journal of Medical and Biological Research
issn 1414-431X
publishDate 2015-05-01
description The present study investigated the effect of silibinin, the principal potential anti-inflammatory flavonoid contained in silymarin, a mixture of flavonolignans extracted from Silybum marianum seeds, on palmitate-induced insulin resistance in C2C12 myotubes and its potential molecular mechanisms. Silibinin prevented the decrease of insulin-stimulated 2-NBDG (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose) uptake and the downregulation of glutamate transporter type 4 (GLUT4) translocation in C2C12 myotubes induced by palmitate. Meanwhile, silibinin suppressed the palmitate-induced decrease of insulin-stimulated Akt Ser473 phosphorylation, which was reversed by wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase (PI3K). We also found that palmitate downregulated insulin-stimulated Tyr632 phosphorylation of insulin receptor substrate 1 (IRS-1) and up-regulated IRS-1 Ser307 phosphorylation. These effects were rebalanced by silibinin. Considering several serine/threonine kinases reported to phosphorylate IRS-1 at Ser307, treatment with silibinin downregulated the phosphorylation of both c-Jun N-terminal kinase (JNK) and nuclear factor-κB kinase β (IKKβ), which was increased by palmitate in C2C12 myotubes mediating inflammatory status, whereas the phosphorylation of PKC-θ was not significantly modulated by silibinin. Collectively, the results indicated that silibinin prevented inhibition of the IRS-1/PI3K/Akt pathway, thus ameliorating palmitate-induced insulin resistance in C2C12 myotubes.
topic Silibinin
Insulin resistance
Palmitate
C2C12
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000500440&lng=en&tlng=en
work_keys_str_mv AT hbli silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition
AT yryyang silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition
AT zjmo silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition
AT yding silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition
AT wjjiang silibininimprovespalmitateinducedinsulinresistanceinc2c12myotubesbyattenuatingirs1pi3kaktpathwayinhibition
_version_ 1725628293712969728